Elixir Capital is a Sydney-based private equity firm investing in the secular trends and supply chains driving technology, healthcare, industrial, and consumer markets in Australia, New Zealand, United Kingdom and Canada. Our broad members have extensive investment and M&A experience across retail, healthcare, media, consumer goods, financial services and other sectors. Some of Elixir Capital’s current and former investments include Venzee (Now listed on TSV as VENZ), Liven, Rightangled, Verv, Mute international, Credentially (Formerly known as drfocused) and Yoller (Formerly known as PlanSnap).